XML 79 R19.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Share-Based Compensation (Notes)
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Share-based Payment Arrangement [Text Block]
Share-Based Compensation
The Company’s outstanding share-based awards consist mainly of non-qualified stock options and restricted shares. As of December 31, 2019, the Company had 32 million shares available for future grants of share-based awards under the Plan. As of December 31, 2019, there were also 5 million shares of common stock available for issuance under the ESPP.
Stock Options
Stock option activity for the year ended December 31, 2019 is summarized in the table below:
 
Shares
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual Life
 
Aggregate
Intrinsic Value
 
(in millions)
 
 
 
(in years)
 
(in millions)
Outstanding at beginning of period
35

 
$
131

 
 
 
 
Granted
7

 
260

 
 
 
 
Exercised
(9
)
 
94

 
 
 
 
Forfeited
(1
)
 
212

 
 
 
 
Outstanding at end of period
32

 
166

 
6.5
 
$
4,106

Exercisable at end of period
15

 
114

 
5.0
 
2,716

Vested and expected to vest, end of period
31

 
165

 
6.4
 
4,068


Restricted Shares
Restricted share activity for the year ended December 31, 2019 is summarized in the table below:
(shares in millions)
 
Shares
 
Weighted-Average
Grant Date
Fair Value
per Share
Nonvested at beginning of period
 
6

 
$
163

Granted
 
2

 
259

Vested
 
(3
)
 
147

Nonvested at end of period
 
5

 
207


Other Share-Based Compensation Data
(in millions, except per share amounts)
 
For the Years Ended December 31,
 
2019
 
2018
 
2017
Stock Options
 
 
 
 
 
 
Weighted-average grant date fair value of shares granted, per share
 
$
46

 
$
43

 
$
29

Total intrinsic value of stock options exercised
 
1,398

 
1,431

 
1,473

Restricted Shares
 
 
 
 
 
 
Weighted-average grant date fair value of shares granted, per share
 
259

 
229

 
163

Total fair value of restricted shares vested
 
$
545

 
$
521

 
$
460

Employee Stock Purchase Plan
 
 
 
 
 
 
Number of shares purchased
 
1

 
2

 
2

Share-Based Compensation Items
 
 
 
 
 
 
Share-based compensation expense, before tax
 
$
697

 
$
638

 
$
597

Share-based compensation expense, net of tax effects
 
641

 
587

 
531

Income tax benefit realized from share-based award exercises
 
201

 
239

 
431

(in millions, except years)
 
December 31, 2019
Unrecognized compensation expense related to share awards
 
$
714

Weighted-average years to recognize compensation expense
 
1.3


Share-Based Compensation Recognition and Estimates
The principal assumptions the Company used in calculating grant-date fair value for stock options were as follows:
 
 
For the Years Ended December 31,
 
 
2019
 
2018
 
2017
Risk-free interest rate
 
1.5% - 2.5%
 
2.6% - 3.1%
 
1.9% - 2.1%
Expected volatility
 
19.4% - 21.6%
 
18.7% - 19.3%
 
18.5% - 20.7%
Expected dividend yield
 
1.4% - 1.8%
 
1.3% - 1.5%
 
1.4% - 1.6%
Forfeiture rate
 
5.0%
 
5.0%
 
5.0%
Expected life in years
 
5.3
 
5.6
 
5.7

Risk-free interest rates are based on U.S. Treasury yields in effect at the time of grant. Expected volatilities are based on the historical volatility of the Company’s common stock and the implied volatility from exchange-traded options on the Company’s common stock. Expected dividend yields are based on the per share cash dividend paid by the Company. The Company uses historical data to estimate option exercises and forfeitures within the valuation model. The expected lives of options granted represents the period of time that the awards granted are expected to be outstanding based on historical exercise patterns.
Other Employee Benefit Plans
The Company offers a 401(k) plan for its employees. Compensation expense related to this plan was not material for 2019, 2018 and 2017.
 
In addition, the Company maintains non-qualified, deferred compensation plans, which allow certain members of senior management and executives to defer portions of their salary or bonus and receive certain Company contributions on such deferrals, subject to plan limitations. The deferrals are recorded within long-term investments with an approximately equal amount in other liabilities in the Consolidated Balance Sheets. The total deferrals are distributable based upon termination of employment or other periods, as elected under each plan and were $1.4 billion and $988 million as of December 31, 2019 and 2018, respectively.